Annual Operating Expenses
$6.05 M
-$3.82 M-38.70%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual total operating expenses is $6.05 million, with the most recent change of -$3.82 million (-38.70%) on December 1, 2023.
- During the last 3 years, XRTX annual operating expenses has risen by +$5.03 million (+492.80%).
- XRTX annual operating expenses is now -38.70% below its all-time high of $9.86 million, reached on December 31, 2022.
Performance
XRTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$874.70 K
-$619.00 K-41.44%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly total operating expenses is $874.70 thousand, with the most recent change of -$619.00 thousand (-41.44%) on September 1, 2024.
- Over the past year, XRTX quarterly operating expenses has dropped by -$109.00 thousand (-11.08%).
- XRTX quarterly operating expenses is now -69.59% below its all-time high of $2.88 million, reached on March 1, 2022.
Performance
XRTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
XRTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.7% | -11.1% |
| 3 y3 years | +492.8% | -54.1% |
| 5 y5 years | +611.6% | -54.1% |
XRTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.7% | +111.2% | -69.6% | at low |
| 5 y | 5-year | -38.7% | +1295.3% | -69.6% | +640.6% |
| alltime | all time | -38.7% | >+9999.0% | -69.6% | +7269.7% |
XORTX Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $874.70 K(-41.4%) |
| Jun 2024 | - | $1.49 M(+37.2%) |
| Mar 2024 | - | $1.09 M(+10.7%) |
| Dec 2023 | $6.05 M(-38.7%) | $983.70 K(-29.4%) |
| Sep 2023 | - | $1.39 M(-20.9%) |
| Jun 2023 | - | $1.76 M(-7.6%) |
| Mar 2023 | - | $1.91 M(-28.3%) |
| Dec 2022 | $9.86 M(+244.6%) | $2.66 M(+26.5%) |
| Sep 2022 | - | $2.10 M(-20.7%) |
| Jun 2022 | - | $2.65 M(-7.8%) |
| Mar 2022 | - | $2.88 M(+119.4%) |
| Dec 2021 | $2.86 M(+180.6%) | - |
| Dec 2021 | - | $1.31 M(+312.9%) |
| Sep 2021 | - | $317.40 K(-54.5%) |
| Jun 2021 | - | $698.00 K(+14.4%) |
| Mar 2021 | - | $610.40 K(+83.6%) |
| Dec 2020 | $1.02 M(+135.4%) | $332.40 K(+16.5%) |
| Sep 2020 | - | $285.30 K(+5.0%) |
| Jun 2020 | - | $271.60 K(+130.0%) |
| Mar 2020 | - | $118.10 K(-9.4%) |
| Dec 2019 | $433.30 K | $130.30 K(+29.5%) |
| Sep 2019 | - | $100.60 K(-5.8%) |
| Jun 2019 | - | $106.80 K(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $125.40 K(+110.1%) |
| Dec 2018 | $849.60 K(+130.2%) | $59.70 K(-73.8%) |
| Sep 2018 | - | $227.50 K(+8.0%) |
| Jun 2018 | - | $210.60 K(-39.5%) |
| Mar 2018 | - | $348.20 K(+84.1%) |
| Dec 2017 | $369.00 K(+151.5%) | $189.10 K(+512.0%) |
| Nov 2017 | - | $30.90 K(-57.3%) |
| Sep 2017 | - | $72.40 K(+34.8%) |
| Aug 2017 | - | $53.70 K(+52.6%) |
| May 2017 | - | $35.20 K(-30.2%) |
| Mar 2017 | - | $50.40 K(+56.0%) |
| Feb 2017 | $146.70 K(-51.4%) | $32.30 K(-24.5%) |
| Dec 2016 | $301.60 K(+99.7%) | - |
| Nov 2016 | - | $42.80 K(+7.5%) |
| Aug 2016 | - | $39.80 K(+17.4%) |
| May 2016 | - | $33.90 K(-377.9%) |
| Feb 2016 | $151.00 K(+411.9%) | -$12.20 K(-115.0%) |
| Nov 2015 | - | $81.60 K(+131.8%) |
| Aug 2015 | - | $35.20 K(-30.2%) |
| May 2015 | - | $50.40 K(+303.2%) |
| Feb 2015 | $29.50 K | $12.50 K(+123.2%) |
| Nov 2014 | - | $5600.00(-8.2%) |
| Aug 2014 | - | $6100.00(+3.4%) |
| May 2014 | - | $5900.00 |
FAQ
- What is XORTX Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for XORTX Therapeutics?
- What is XORTX Therapeutics annual operating expenses year-on-year change?
- What is XORTX Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly operating expenses year-on-year change?
What is XORTX Therapeutics annual total operating expenses?
The current annual operating expenses of XRTX is $6.05 M
What is the all time high annual operating expenses for XORTX Therapeutics?
XORTX Therapeutics all-time high annual total operating expenses is $9.86 M
What is XORTX Therapeutics annual operating expenses year-on-year change?
Over the past year, XRTX annual total operating expenses has changed by -$3.82 M (-38.70%)
What is XORTX Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of XRTX is $874.70 K
What is the all time high quarterly operating expenses for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly total operating expenses is $2.88 M
What is XORTX Therapeutics quarterly operating expenses year-on-year change?
Over the past year, XRTX quarterly total operating expenses has changed by -$109.00 K (-11.08%)